BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38472614)

  • 1. Pictures at an exhibition: A commentary on Benn & Robinson (2024).
    Setlow B; Burns MR
    Cogn Affect Behav Neurosci; 2024 Apr; 24(2):368-369. PubMed ID: 38472614
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a novel rodent rapid serial visual presentation task reveals dissociable effects of stimulant versus nonstimulant treatments on attentional processes.
    Benn A; Robinson ESJ
    Cogn Affect Behav Neurosci; 2024 Apr; 24(2):351-367. PubMed ID: 38253774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of d-amphetamine and atomoxetine on risk-based decision making of Lewis and Fischer 344 rats.
    Ozga-Hess JE; Anderson KG
    Behav Pharmacol; 2019 Oct; 30(7):605-616. PubMed ID: 31503070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder: A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.
    Pozzi M; Carnovale C; Mazhar F; Peeters GGAM; Gentili M; Nobile M; Radice S; Clementi E
    J Clin Psychopharmacol; 2019; 39(4):386-392. PubMed ID: 31205193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system.
    Wei W; Chen L; Zhou H; Liu J; Zhang Y; Feng S; Bai Y; Leng Y; Chang E; Huang L
    Front Pharmacol; 2023; 14():1208456. PubMed ID: 37645441
    [No Abstract]   [Full Text] [Related]  

  • 7. Theory of visual attention (TVA) applied to rats performing the 5-choice serial reaction time task: differential effects of dopaminergic and noradrenergic manipulations.
    Hervig ME; Toschi C; Petersen A; Vangkilde S; Gether U; Robbins TW
    Psychopharmacology (Berl); 2023 Jan; 240(1):41-58. PubMed ID: 36434307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test.
    Caballero-Puntiverio M; Lerdrup LS; Grupe M; Larsen CW; Dietz AG; Andreasen JT
    Psychopharmacology (Berl); 2019 Jun; 236(6):1839-1851. PubMed ID: 30656365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles for cortical versus sub-cortical noradrenaline and modulation of impulsivity in the rat.
    Benn A; Robinson ES
    Psychopharmacology (Berl); 2017 Jan; 234(2):255-266. PubMed ID: 27744551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults.
    Hamard J; Rousseau V; Durrieu G; Garcia P; Yrondi A; Sommet A; Revet A; Montastruc F
    BMJ Ment Health; 2024 Apr; 27(1):. PubMed ID: 38609318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the relationship of weight to height, and thus the meaning of BMI, according to age, sex, and birth year cohort.
    Johnson W; Norris T; Bann D; Cameron N; Wells JK; Cole TJ; Hardy R
    Ann Hum Biol; 2020 Mar; 47(2):199-207. PubMed ID: 32429756
    [No Abstract]   [Full Text] [Related]  

  • 12. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index and age at menarche in Peruvian children living at high altitude and at sea level.
    Gonzales GF; Villena A
    Hum Biol; 1996 Apr; 68(2):265-75. PubMed ID: 8838916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test.
    Ding Z; Brown JW; Rueter LE; Mohler EG
    Psychopharmacology (Berl); 2018 Apr; 235(4):1093-1105. PubMed ID: 29332255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valence-space associations in touchscreen interactions: Valence match between emotional pictures and their vertical touch location leads to pictures' positive evaluation.
    Cervera-Torres S; Ruiz Fernández S; Lachmair M; Gerjets P
    PLoS One; 2018; 13(7):e0199972. PubMed ID: 30020949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine's effect on impulsive action in adulthood.
    Silveira MM; Murch WS; Clark L; Winstanley CA
    Behav Pharmacol; 2016 Jun; 27(4):350-63. PubMed ID: 26650252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
    Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with an autism-associated R451C mutation in neuroligin-3 show intact attention orienting but atypical responses to methylphenidate and atomoxetine in the mouse-Posner task.
    Li S; May C; Pang TY; Churilov L; Hannan AJ; Johnson KA; Burrows EL
    Psychopharmacology (Berl); 2024 Mar; 241(3):555-567. PubMed ID: 38170320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
    Eiland LS; Bell EA; Erramouspe J
    Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.